Supporting Just-In-Time Consent for Prenatal Screening: The INFORM Study
NCT07557303
Adherence Interventions, Behavior
San Francisco, California, United States
View Trial DetailsNCT Number: NCT06721481
The purpose of this study is to investigate the specific features of radiofrequencies (RF) exposure (including 5G) in pregnant women, its evolution during pregnancy and the quantitative contribution of the various RF emission sources to which they are exposed.
Trial opening soon.
Get Notified18 year and older
Female
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 days
Women have to wear a personal portable exposure meter during 3 days.
Time frame: 3 periods of 3 days
The measurement is repeted for each trimester of pregnancy
Contact information is provided by the study sponsor or research team.
Frédéric Mauny, Professor
CONTACT
++33 3 81 21 94 94
Sophie Pujol, PhD
CONTACT
Centre Hospitalier Universitaire de Besancon
Other
Radiofrequency Electromagnetic Fields and Pregnancy : Exposure Specificities and Evolution: the RFM - Expo Study
Acronym: RFM - Expo
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07557303
Adherence Interventions, Behavior
San Francisco, California, United States
View Trial DetailsNCT07717502
Nulliparous Women Who Scheduled for Labor Induction, Pregnancy
New Orleans, Louisiana, United States
View Trial DetailsNCT07708129
Large for Gestational Age (LGA), Pregnancy
View Trial DetailsNCT07699978
Female Urogenital Diseases and Pregnancy Complications, Inflammation
View Trial Details